Arab Journal of Gastroenterology最新文献

筛选
英文 中文
Establishing consensus on Arabic medical terminology for steatotic liver disease: a mixed-methods approach 建立对脂肪变性肝病阿拉伯医学术语的共识:混合方法方法。
IF 1.1 4区 医学
Arab Journal of Gastroenterology Pub Date : 2025-05-01 DOI: 10.1016/j.ajg.2025.01.009
Mohamed El-Kassas , Khalid Al-Naamani , Mohamed Elbadry , Abeer Awad , Mina Tharwat , Nabil Debzi , Shahrazed Zemmouchi , Maheeba Abdulla , Doaa Zakaria , Gamal Esmat , Hanaa El-Karaksy , Imam Waked , Inass Shaltout , Mohammed A. Medhat , Mortada El-Shabrawi , Nermeen Abdeen , Mudher Al-khairalla , Maisam W. Akroush , Ali A. Alali , Maen Almattooq , Khalid Alswat
{"title":"Establishing consensus on Arabic medical terminology for steatotic liver disease: a mixed-methods approach","authors":"Mohamed El-Kassas , Khalid Al-Naamani , Mohamed Elbadry , Abeer Awad , Mina Tharwat , Nabil Debzi , Shahrazed Zemmouchi , Maheeba Abdulla , Doaa Zakaria , Gamal Esmat , Hanaa El-Karaksy , Imam Waked , Inass Shaltout , Mohammed A. Medhat , Mortada El-Shabrawi , Nermeen Abdeen , Mudher Al-khairalla , Maisam W. Akroush , Ali A. Alali , Maen Almattooq , Khalid Alswat","doi":"10.1016/j.ajg.2025.01.009","DOIUrl":"10.1016/j.ajg.2025.01.009","url":null,"abstract":"","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":"26 2","pages":"Pages 143-148"},"PeriodicalIF":1.1,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144086527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mesenchymal stem cell derived exosomes as Nanodrug carrier of doxorubicin combined with PVT1 siRNA inhibits the progression of gastric cancer 间充质干细胞外泌体作为纳米药物载体联合PVT1 siRNA抑制胃癌的进展。
IF 1.1 4区 医学
Arab Journal of Gastroenterology Pub Date : 2025-05-01 DOI: 10.1016/j.ajg.2025.01.012
Deliang Ouyang, Haibin Li, Kang Luo, Mingming Huang, Song Yan, Li Zhou
{"title":"Mesenchymal stem cell derived exosomes as Nanodrug carrier of doxorubicin combined with PVT1 siRNA inhibits the progression of gastric cancer","authors":"Deliang Ouyang,&nbsp;Haibin Li,&nbsp;Kang Luo,&nbsp;Mingming Huang,&nbsp;Song Yan,&nbsp;Li Zhou","doi":"10.1016/j.ajg.2025.01.012","DOIUrl":"10.1016/j.ajg.2025.01.012","url":null,"abstract":"<div><h3>Background and study aims</h3><div>Mesenchymal stem cell-derived exosomes (MSC-Exos) have been used as drug delivery vehicles for the treatment of gastric cancer. This study aimed to explore the effects of doxorubicin-loaded exosomes (Exo-Dox) combined with the long noncoding RNA PVT1 on gastric cancer (GC) development.</div></div><div><h3>Material and methods</h3><div>CCK-8 and immunohistochemistry were used to assess cell proliferation. The morphology and size of the exosomes and Exo-Dox were determined. The distribution of free Exos and Exo-Dox in cells was observed under a fluorescence microscope. Cell migration and invasive ability were assessed using wound healing and Transwell assays. In addition, the protective effects of Exo-Dox were confirmed in a xenograft tumor model.</div></div><div><h3>Results</h3><div>Exosomes were successfully isolated from MSCs and identified. The size of Exo-Dox was greater than that of free Exos. The acidic environment promoted the release of doxorubicin, and exosomes promoted the cellular uptake of doxorubicin. Compared with doxorubicin alone, Exo-Dox exhibited better antitumor effects on gastric cancer, inhibiting the growth, migration and invasion of gastric cancer cells. Additionally, combined therapy of Exo-Dox with si-PVT1 clearly suppressed the proliferation, migration and invasive ability of gastric cancer cells. Exo-Dox combined with si-PVT1 inhibited tumor growth and metastasis in a xenograft model.</div></div><div><h3>Conclusion</h3><div>Doxorubicin-loaded exosomes combined with si-PVT1 suppressed the progression of GC.</div></div>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":"26 2","pages":"Pages 149-156"},"PeriodicalIF":1.1,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144053890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel rotatable sphincterotome for transpancreatic biliary sphincterotomy via balloon enteroscopy in a patient with Roux-en-Y gastrectomy 一种新型的可旋转括约肌切开术,用于经胰胆道括约肌切开术,经球囊肠镜治疗Roux-en-Y胃切除术患者。
IF 1.1 4区 医学
Arab Journal of Gastroenterology Pub Date : 2025-05-01 DOI: 10.1016/j.ajg.2025.02.007
Yuki Tanisaka, Shomei Ryozawa, Masafumi Mizuide, Akashi Fujita, Ryuichi Watanabe
{"title":"A novel rotatable sphincterotome for transpancreatic biliary sphincterotomy via balloon enteroscopy in a patient with Roux-en-Y gastrectomy","authors":"Yuki Tanisaka,&nbsp;Shomei Ryozawa,&nbsp;Masafumi Mizuide,&nbsp;Akashi Fujita,&nbsp;Ryuichi Watanabe","doi":"10.1016/j.ajg.2025.02.007","DOIUrl":"10.1016/j.ajg.2025.02.007","url":null,"abstract":"","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":"26 2","pages":"Pages 219-221"},"PeriodicalIF":1.1,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144054897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RNF186 gene variant and zonulin levels in inflammatory bowel disease: A pilot study 炎症性肠病的RNF186基因变异和zonulin水平:一项初步研究
IF 1.1 4区 医学
Arab Journal of Gastroenterology Pub Date : 2025-05-01 DOI: 10.1016/j.ajg.2025.02.005
Elif Özdemir Güneri , Resul Kahraman , Merve Nur Ataş , Arzu Ergen
{"title":"RNF186 gene variant and zonulin levels in inflammatory bowel disease: A pilot study","authors":"Elif Özdemir Güneri ,&nbsp;Resul Kahraman ,&nbsp;Merve Nur Ataş ,&nbsp;Arzu Ergen","doi":"10.1016/j.ajg.2025.02.005","DOIUrl":"10.1016/j.ajg.2025.02.005","url":null,"abstract":"<div><h3>Background and study aim</h3><div>Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract characterized by inflammation and ulceration of the intestinal mucosa, represented by Crohn’s disease (CD) and ulcerative colitis (UC). The aim of this study is to investigate the relationship between the Ring Finger Protein 186 (RNF186) rs3806308 variant and IBD, as well as to determine whether zonulin levels are associated with IBD.</div></div><div><h3>Patients and methods</h3><div>Ninety-nine patients with inflammatory bowel disease were included in the study. The real-time PCR method was used to detect RNF186 gene polymorphism. Also serum zonulin levels were determined by using Enzyme Linked Immunosorbent Assay (ELISA) technique.</div></div><div><h3>Results</h3><div>No difference was found between the groups in terms of RNF186 genotype and allele distributions (p &gt; 0.05). CC genotype was associated with high levels of C-reactive protein (CRP) in total patients and CD compared to CT (p &lt; 0.05).</div></div><div><h3>Conclusion</h3><div>The present study is the first study conducted in our country in terms of examining RNF 186 gene polymorphism and serum zonulin levels.</div></div>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":"26 2","pages":"Pages 207-211"},"PeriodicalIF":1.1,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144064920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prevalence of infection and potential risk factors for HBV and HCV among healthcare workers not vaccinated against HBV: A study from a cancer center in Egypt, 2021–2022 未接种HBV疫苗的医护人员中HBV和HCV感染流行率和潜在危险因素:2021-2022年埃及癌症中心的一项研究
IF 1.1 4区 医学
Arab Journal of Gastroenterology Pub Date : 2025-05-01 DOI: 10.1016/j.ajg.2025.01.013
Douaa Sayed , Rania Bakry , Nabiel Mikhail , Medhat Faris , Fatma Rageh , Ahmed Samir Abdelhafiz , Dalia Ghareeb
{"title":"The prevalence of infection and potential risk factors for HBV and HCV among healthcare workers not vaccinated against HBV: A study from a cancer center in Egypt, 2021–2022","authors":"Douaa Sayed ,&nbsp;Rania Bakry ,&nbsp;Nabiel Mikhail ,&nbsp;Medhat Faris ,&nbsp;Fatma Rageh ,&nbsp;Ahmed Samir Abdelhafiz ,&nbsp;Dalia Ghareeb","doi":"10.1016/j.ajg.2025.01.013","DOIUrl":"10.1016/j.ajg.2025.01.013","url":null,"abstract":"<div><h3>Background and study aim</h3><div>South Egypt Cancer Institute (SECI) is the largest oncology university hospital in Upper Egypt. HBV and HCV are amongst the most important viral infections in cancer patients due to their impaired immunity. Nosocomial infection is among the most important sources of infections of these viruses. However, estimation for the prevalence of HBV and HCV infections among healthcare workers (HCWs) dealing with oncology patients as well as identifying HCV genotypes have not been recently investigated.</div></div><div><h3>Methods</h3><div>The study consisted of a survey of HCWs in direct contact with blood as a part of their daily work. HCV/Ab, HBsAg and anti-HBc IgM were detected in 505 employees, RT-PCR was performed on HCV-positive persons.</div></div><div><h3>Results</h3><div>Prevalence was 7.5 % for HCV with marked drop in younger age group and 2.0 % for HBV. The age groups affected were mostly from 30 to &lt; 40 for HBV and ≥ 50 years for HCV. Three-quarters of anti-HCV-positive were also positive by RT-PCR. Males had significantly more HBV infections than females. Gender didn’t affect the rates of HCV infection.<!--> <!-->HCV genotyping was determined in 20 HCWs who were positive for HCV-RNA. Except for only one, all infections were HCV genotype 4. The commonest place for exposure to HCV was the pediatric inpatient wards (14.3 %), while operation rooms and adult inpatient wards were the highest exposure places for HBV (5.1 % and 2.6 %, respectively).</div></div><div><h3>Conclusions</h3><div>The marked drop in the prevalence of HCV infection, as well as the relatively lower prevalence of HBV infection among HCWs provides evidence for the effectiveness of infection control measures applied in healthcare over the past few years.</div></div>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":"26 2","pages":"Pages 201-206"},"PeriodicalIF":1.1,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144051333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel nomogram for predicting the risk of coronary atherosclerosis in patients with gastroesophageal reflux disease 一种预测胃食管反流病患者冠状动脉粥样硬化风险的新nomogram。
IF 1.1 4区 医学
Arab Journal of Gastroenterology Pub Date : 2025-05-01 DOI: 10.1016/j.ajg.2025.02.003
Ziyang Wu , Dong Wang , Chengchun Tang
{"title":"A novel nomogram for predicting the risk of coronary atherosclerosis in patients with gastroesophageal reflux disease","authors":"Ziyang Wu ,&nbsp;Dong Wang ,&nbsp;Chengchun Tang","doi":"10.1016/j.ajg.2025.02.003","DOIUrl":"10.1016/j.ajg.2025.02.003","url":null,"abstract":"<div><h3>Background and study aims</h3><div>This study developed a novel nomogram to predict the incidence of coronary atherosclerosis (CA) in patients with gastroesophageal reflux disease (GERD) and evaluated its predictive value.</div></div><div><h3>Patients and methods</h3><div>In total, 13,658 patients with GERD from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database were analyzed. The patients were randomly divided into a training cohort (n = 9,560) and a validation cohort (n = 4,098) at a 7:3 ratio. Least absolute shrinkage and selection operator (LASSO) regression analyses were performed to identify associated risk variables. Then a nomogram was developed to predict the rate of CA in patients with GERD. The model’s performance was evaluated using the concordance index, area under the receiver operating characteristic curve, calibration curve, and decision curve analysis.</div></div><div><h3>Results</h3><div>LASSO regression identified nine potential predictors of CA. Multivariate logistic regression was used to evaluate these predictors and establish the final model. The concordance index was 0.750. The areas under the curve for the training and validation cohorts were 0.7500 and 0.7297, respectively.</div></div><div><h3>Conclusion</h3><div>Age, white blood cell count, hemoglobin, mean corpuscular hemoglobin, mean corpuscular volume, sodium, bicarbonate, creatinine, and chloride were identified as predictors of CA. The developed nomogram provides a reliable and convenient tool for predicting CA in patients with GERD.</div></div>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":"26 2","pages":"Pages 176-184"},"PeriodicalIF":1.1,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144035596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors and correlation of intestinal metaplasia: A case- control study in Wuwei 武威市肠化生危险因素及相关性的病例对照研究。
IF 1.1 4区 医学
Arab Journal of Gastroenterology Pub Date : 2025-05-01 DOI: 10.1016/j.ajg.2025.02.004
Agnes Maganga , Solomon Boamah , Jianjun Wu , Bilembi Mboté Olivier
{"title":"Risk factors and correlation of intestinal metaplasia: A case- control study in Wuwei","authors":"Agnes Maganga ,&nbsp;Solomon Boamah ,&nbsp;Jianjun Wu ,&nbsp;Bilembi Mboté Olivier","doi":"10.1016/j.ajg.2025.02.004","DOIUrl":"10.1016/j.ajg.2025.02.004","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;Intestinal metaplasia (IM) is a significant gastric mucosal change that warrants attention due to its potential role in the pathogenesis of gastric cancer. IM is often triggered by &lt;em&gt;Helicobacter pylori&lt;/em&gt; (&lt;em&gt;H. pylori&lt;/em&gt;) infection and some risk factors.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Patients and methods&lt;/h3&gt;&lt;div&gt;This study examined &lt;em&gt;H. pylori&lt;/em&gt; infection and related risk factors in 7,096 participants, identifying 2,200 cases of IM linked to &lt;em&gt;H. pylori&lt;/em&gt; and 4,896 controls without the infection in Wuwei, Gansu Province, China. The Operative Link on Gastritis/Intestinal Metaplasia (OLGIM) and (Operative Link on Gastritis Assessment (OLGA) classifications tools were used for identifying participants at high risk for gastric cancer by evaluating the severity and extent of &lt;em&gt;H. pylori&lt;/em&gt; infection and IM.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;The study found that IM and &lt;em&gt;H. pylori&lt;/em&gt; prevalence were gender-related, with males representing 41.09 % of cases compared to 33.92 % of controls, a significant difference (&lt;em&gt;P&lt;/em&gt; &lt; 0.0001). Conversely, females were more prevalent in the control group (66.07 %) compared to the case group (58.91 %). Age analysis showed higher proportions of IM cases in the 40–49 years group (46.95 %) compared to controls (43.40 %), with significant differences across age groups (&lt;em&gt;P&lt;/em&gt; &lt; 0.0001). IM showed significant positive correlations with smoking , alcohol consumption , and drinking water sources . &lt;em&gt;H. pylori&lt;/em&gt; infection was detected in 238 (10.81 %) of the case group and 542 (11.07 %) of the control group. Using the OLGIM classification, which incorporates IM into gastric cancer risk assessment, stage 0 (no IM) was observed in 1,189 (24.28 %) of the control group and 530 (24.09 %) of the case group. Stage 1 (mild IM) was found in 3,165 (64.62 %) of the controls and 1,432 (65.09 %) of the cases. Stage 2 (moderate IM) was present in 520 (10.62 %) of the controls and 220 (10 %) of the cases, while stage 3 (severe IM) was observed in 24 (0.49 %) of the controls and 18 (0.82 %) of the cases. For OLGA staging, the case group had a higher percentage of individuals in higher stages (III and IV) compared to the control group. Specifically, 50.84 % of the cases were classified as stage 0, 19.75 % , stage I, 14.71 %, stage II, 8.40 %, stage III, and IV, 6.30 %. In the control group, 54.43 % were classified as stage 0, 24.17 %, stage I, 18.45 %, stage II, 1.66 %, stage III, and IV, 1.29 % respectively.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusions&lt;/h3&gt;&lt;div&gt;These findings suggest that older individuals, males, smokers, drinkers, and those using certain drinking water sources are more likely to develop IM. The study highlights the combined impact of &lt;em&gt;H. pylori&lt;/em&gt; and risk factors on IM development, emphasizing the need for comprehensive public health strategies to address these risks. The higher proportion of advanced OLGA stages in the case group suggests more severe gastric a","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":"26 2","pages":"Pages 185-194"},"PeriodicalIF":1.1,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144026337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in liver stiffness and non-invasive markers in chronic hepatitis C virus patients with and without HIV co-infection following interferon-free antiviral treatment 无干扰素抗病毒治疗后伴有和不伴有HIV合并感染的慢性丙型肝炎患者肝脏硬度和非侵入性标志物的变化
IF 1.1 4区 医学
Arab Journal of Gastroenterology Pub Date : 2025-05-01 DOI: 10.1016/j.ajg.2025.02.006
Shereen Abdel Alem, Zeinab abdellatif, Rahma Mohamed, Aisha Elsharkawy, Rabab Fouad, Gamal Esmat, Ahmed Cordie
{"title":"Changes in liver stiffness and non-invasive markers in chronic hepatitis C virus patients with and without HIV co-infection following interferon-free antiviral treatment","authors":"Shereen Abdel Alem,&nbsp;Zeinab abdellatif,&nbsp;Rahma Mohamed,&nbsp;Aisha Elsharkawy,&nbsp;Rabab Fouad,&nbsp;Gamal Esmat,&nbsp;Ahmed Cordie","doi":"10.1016/j.ajg.2025.02.006","DOIUrl":"10.1016/j.ajg.2025.02.006","url":null,"abstract":"<div><h3>Background and study aims</h3><div>HIV alone can induce liver fibrosis whereas co-infection with HCV presents a significant challenge in hastening the development of chronic liver disorders such a liver fibrosis, cirrhosis, and hepatic malignancy. Information on the influence of HIV on liver stiffness (LS) after treatment with direct-acting antiviral (DAAs) agents is scarce. The aim of this study was to assess the changes in LS using transient elastography (TE) and fibrosis scores (Fibrosis-4 [FIB-4] and AST-to-platelet ratio index [APRI]) before the initiation of treatment and six months after the end of treatment (EOT) with DAAs in HCV/HIV co-infected patients compared with HCV mono-infected patients.</div></div><div><h3>Patients and methods</h3><div>All consecutive chronic HCV patients treated with DAAs during 2016–2020 were retrospectively recruited. TE was performed at baseline and SVR24. Fibrosis scores such as FIB-4 and APRI were calculated in parallel. Improvement of liver fibrosis was defined as any changes in the fibrosis category at baseline to a lower fibrosis category at SVR24.</div></div><div><h3>Results</h3><div>Of 288 HCV-infected patients, 217 (75.3 %) were HCV mono-infected and 71 (24.7 %) were HCV/HIV co-infected. A significant decrease in TE values was noted at SVR24 compared with baseline (10.3 kPa vs. 7.9 kPa, respectively; P= &lt;0.0001 in HCV mono-infection; 5.9 kPa vs. 5.3 kPa, respectively; P= &lt;0.0001 in HCV/HIV co-infection). Moreover, the proportion of HCV mono-infected patients who had stable, improvement, and worsening in fibrosis stage at follow-up was 50.2 %, 43.3 %, and 6.5 %, respectively while it was 54.9 %, 32.4 %, and 12.7 %, respectively in HCV/HIV co-infection. In multivariable analysis, the higher fibrosis category was the only factor that influenced the improvement of liver fibrosis at follow-up, whereas HIV co-infection wasn’t confirmed.</div></div><div><h3>Conclusion</h3><div>patients with HCV mono-infection and HCV/HIV co-infection experienced a rapid and significant improvement in LS and fibrosis indices. This improvement was more pronounced in those with high fibrosis grades at baseline.</div></div>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":"26 2","pages":"Pages 212-218"},"PeriodicalIF":1.1,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144051359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of a tip-tapered hood for diverticular bleeding with inflammation 尖顶帽治疗憩室出血伴炎症的疗效观察。
IF 1.1 4区 医学
Arab Journal of Gastroenterology Pub Date : 2025-05-01 DOI: 10.1016/j.ajg.2025.02.002
Daisuke Murakami , Takanori Shimizu , Makoto Arai
{"title":"Efficacy of a tip-tapered hood for diverticular bleeding with inflammation","authors":"Daisuke Murakami ,&nbsp;Takanori Shimizu ,&nbsp;Makoto Arai","doi":"10.1016/j.ajg.2025.02.002","DOIUrl":"10.1016/j.ajg.2025.02.002","url":null,"abstract":"","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":"26 2","pages":"Pages 222-223"},"PeriodicalIF":1.1,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144055302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment with antituberculosis agents after tuberculosis activation during ustekinumab treatment: Safety and effectiveness 在乌司替单抗治疗期间,结核病激活后的抗结核药物治疗:安全性和有效性。
IF 1.1 4区 医学
Arab Journal of Gastroenterology Pub Date : 2025-02-01 DOI: 10.1016/j.ajg.2024.01.010
Zhizhi Wang, Wangdi Liao, Youxiang Chen, Shunhua Long
{"title":"Treatment with antituberculosis agents after tuberculosis activation during ustekinumab treatment: Safety and effectiveness","authors":"Zhizhi Wang,&nbsp;Wangdi Liao,&nbsp;Youxiang Chen,&nbsp;Shunhua Long","doi":"10.1016/j.ajg.2024.01.010","DOIUrl":"10.1016/j.ajg.2024.01.010","url":null,"abstract":"<div><div>We report, for the first time, the safety and effectiveness of antituberculosis drugs after tuberculosis activation during ustekinumab treatment in Crohn’s disease.</div></div>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":"26 1","pages":"Pages 23-25"},"PeriodicalIF":1.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139997945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信